17-75763146-G-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000154.2(GALK1):c.479C>A(p.Ser160*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. S160S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000154.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- galactokinase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Myriad Women’s Health, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000154.2. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALK1 | TSL:1 MANE Select | c.479C>A | p.Ser160* | stop_gained | Exon 4 of 8 | ENSP00000465930.1 | P51570 | ||
| GALK1 | TSL:1 | n.*373C>A | non_coding_transcript_exon | Exon 4 of 4 | ENSP00000468288.1 | K7ERJ9 | |||
| GALK1 | TSL:1 | n.*373C>A | 3_prime_UTR | Exon 4 of 4 | ENSP00000468288.1 | K7ERJ9 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1459362Hom.: 0 Cov.: 50 AF XY: 0.00 AC XY: 0AN XY: 726070
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at